<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">93142</article-id><article-id pub-id-type="doi">10.7554/eLife.93142</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>A population modification gene drive targeting both <italic>Saglin</italic> and <italic>Lipophorin</italic> impairs <italic>Plasmodium</italic> transmission in <italic>Anopheles</italic> mosquitoes</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-337828"><name><surname>Green</surname><given-names>Emily I</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-337829"><name><surname>Jaouen</surname><given-names>Etienne</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-59765"><name><surname>Klug</surname><given-names>Dennis</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9108-454X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265073"><name><surname>Proveti Olmo</surname><given-names>Roenick</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3849-8591</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-337830"><name><surname>Gautier</surname><given-names>Amandine</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-201371"><name><surname>Blandin</surname><given-names>Stéphanie</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4566-1200</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-191788"><name><surname>Marois</surname><given-names>Eric</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4147-3747</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">CNRS UPR9022, INSERM U963</institution>, <institution>Inserm, CNRS, University of Strasbourg</institution>, <addr-line><named-content content-type="city">Strasbourg</named-content></addr-line>, <country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-14375"><name><surname>Catteruccia</surname><given-names>Flaminia</given-names></name><role>Reviewing editor</role><aff><institution>Harvard TH Chan School of Public Health</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>e.marois@unistra.fr</email> (EM);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>05</day><month>12</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e93142</elocation-id><history><date date-type="received"><day>02</day><month>10</month><year>2023</year></date><date date-type="accepted"><day>14</day><month>11</month><year>2023</year></date></history><permissions><copyright-statement>© 2023, Green et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Green et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-93142-v1.pdf"/><abstract><p>Lipophorin is an essential, highly expressed lipid transport protein that is secreted and circulates in insect hemolymph. We hijacked the <italic>Anopheles coluzzii</italic> <italic>Lipophorin</italic> gene to make it co-express a single-chain version of antibody 2A10, which binds sporozoites of the malaria parasite <italic>Plasmodium falciparum</italic>. The resulting transgenic mosquitoes show a markedly decreased ability to transmit <italic>Plasmodium berghei</italic> expressing the <italic>P. falciparum</italic> circumsporozoite protein to mice. To force the spread of this anti-malarial transgene in a mosquito population, we designed and tested several CRISPR/Cas9-based gene drives. One of these is installed in, and disrupts, the pro-parasitic gene <italic>Saglin </italic>and also cleaves wild-type <italic>Lipophorin</italic>, causing the anti-malarial modified <italic>Lipophorin</italic> version to replace the wild type and hitch-hike together with the <italic>Saglin</italic> drive. Although generating drive-resistant alleles and showing instability in its gRNA-encoding multiplex array, the <italic>Saglin</italic>-based gene drive reached high levels in caged mosquito populations and efficiently promoted the simultaneous spread of the antimalarial <italic>Lipophorin::Sc2A10</italic> allele. This combination is expected to decrease parasite transmission via two different mechanisms. This work contributes to the design of novel strategies to spread antimalarial transgenes in mosquitoes, and illustrates some expected and unexpected outcomes encountered when establishing a population modification gene drive.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>ANR</institution></institution-wrap></funding-source><award-id>ANR-19-CE35-0007-01</award-id><principal-award-recipient><name><surname>Marois</surname><given-names>Eric</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>ANR</institution></institution-wrap></funding-source><award-id>ANR-11-LABX-0024</award-id><principal-award-recipient><name><surname>Blandin</surname><given-names>Stéphanie</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>ANR</institution></institution-wrap></funding-source><award-id>#ANR-11-EQPX-0022</award-id><principal-award-recipient><name><surname>Marois</surname><given-names>Eric</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>DFG</institution></institution-wrap></funding-source><award-id>#KL 3251/1-1</award-id><principal-award-recipient><name><surname>Klug</surname><given-names>Dennis</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Work on mice was evaluated by the CREMEAS Ethics committee and authorized by Ministère de l'Enseignement Supérieur et de la Recherche (MESRI) under reference APAFIS #20562-2019050313288887v3. Work with genetically modified mosquitoes was evaluated by Haut Conseil des Biotechnologies and authorized by MESRI (agréments d'utilisation d'OGM en milieu confiné #3243 and #3912).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting file.</p></sec><supplementary-material><ext-link xlink:href="elife-93142-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>